Per Subject Cost Sample Clauses

Per Subject Cost. The Per-Subject Cost as defined in Exhibit 1 is based upon completion of all visits and procedures in accordance with the Study specifications set forth in the Protocol. Payments will be calculated based on Study Data entered into EDC system and will be paid as long as the Center is in compliance with the Protocol and the terms of the Agreement including the submission of an invoice where required. CRO will make payments on a quarterly basis within forty-five (45) days of completion of each activity period based upon the 2. Náklady na účastníka klinického skúšania: Náklady na účastníka klinického skúšania, ako sú definované v prílohe č. 1, vychádzajú z absolvovania všetkých návštev a procedúr v súlade so špecifikáciami Klinického skúšania ustanovenými v Protokole. Platby sa vypočítajú na základe údajov z Klinického skúšania zadaných do elektronického systému údajov (EDC) a budú poukázané, pokiaľ Centrum koná v súlade s Protokolom a s podmienkami Zmluvy vrátane predloženia faktúry, ak sa to vyžaduje. CRO bude poukazovať platby štvrťročne do Meno Hl. skúšajúceho / PI Name: XXXx. Xxxxx Xxxxxx, PhD. Príjemca platby / Payee: Fakultná nemocnica F.D.Roosevelta Banská Bystrica Nazov banky / Bank name: IBAN: SWIFT: Referenčné číslo (variabilní symbol) / Referrence no.: Číslo Protokolu / Protocol no.C4221015 DIČ / Tax ID Number: SK2021095670
Sample 1
AutoNDA by SimpleDocs
Per Subject Cost. The Per-Subject Cost as defined in Exhibit 1 is based upon completion of all visits and procedures in accordance with the Study specifications set forth in the Protocol. Payments will be calculated based on Study Data entered into EDC system and will be paid as long as the site is in compliance with the Protocol and the terms of the Agreement including the submission of an invoice where required. CRO will make payments on a quarterly basis within forty-five (45) days of completion of each activity period based upon the services completed during the previous three (3) months. The initial activity period will begin on the first day of the month in which the first patient is screened.
Sample 1
Per Subject Cost. The per-subject cost is based upon completion of all visits and procedures in accordance with the Study specifications set forth in the Protocol. Payments will be made quarterly within 60 days of receipt of invoice for completed visits as confirmed by Study Data received by Pfizer and CRO and as approved by the CRO Study team as long as the site is in compliance with the Protocol and the terms of this Agreement. Invoice will be issued by the Payee on the basis of a calculation made by CRO, within 15 days of receipt of the calculation to the Institution. The calculation will be provided for all items in the budget. The date of taxable delivery is the date of delivery of the calculation to the Institution. In case of late payment the Institution is entitled to charge interest at the statutory rate. In case, that sponsor does not deliver the calculation to the institution in a timely manner in accordance with the timelines set out above, and in case of late payment, the institution is authorized to suspend the data entry into the database until the relevant payment has been made.
Sample 1
Per Subject Cost. The per-subject cost is based upon completion of all visits and procedures in accordance with the Study specifications set forth in the Protocol. Payments will be calculated based Instituce / Institution: Fakultní nemocnice u sv. Anny v Brně Číslo účtu/Account Number: Příjemce platby/Payee: Fakultní nemocnice u sv. Anny v Brně Adresa příjemce platby/Payee’s Address: Xxxxxxxx 00, Xxxx 000 00 XXXX: SWIFT: Telefon příjemce platby/Payee’s Phone Number: E-mailová adresa příjemce pro zasílání podkladů pro vystavení faktur/Payee’s AP/Payment Contact Email address for sending documentation for the invoices xxxxxxxxx.xxxxxx@xxxxx.xx DIČ/Tax ID Number: CZ00159816 Variabilní symbol / Specific symbol: Číslo faktury / Invoice number Platby budou vypočteny dle Údajů studie, které obdrží CRO a společnost Pfizer, a budou vyplaceny, pokud studijní pracoviště splní Protokol a podmínky této Smlouvy o provedení klinického hodnocení, jakož i podmínek této Objednávky studie; CRO bude platby provádět čtvrtletně. on Study Data received by CRO and Pfizer and will be paid as long as the site is in compliance with the Protocol and the terms of this Agreement/ Agreement and the terms of this Study Order CRO will make payments on a quarterly basis
Sample 1
Per Subject Cost. A. NÁKLADY NA SUBJEKT: The per-subject cost is based upon completion of all visits and procedures in accordance with the Study specifications set forth in the Protocol. Payments will be calculated based on Study Data received by Sponsor and CRO and approved by the CRO Study team and will be paid every quarter, as long as the site is in compliance with the Protocol. The per-subject total includes overhead. Náklady na subjekt jsou stanoveny na základě dokončení všech návštěv a postupů v souladu se specifikacemi studie uvedenými v protokolu. Platby budou vypočteny na základě studijních údajů od zadavatele a CRO a schválené studijním týmem CRO, a budou vypláceny každé čtvrtletí za předpokladu, že pracoviště bude dodržovat protokol. Celkové náklady na subjekt zahrnují režijní náklady.
Sample 1
Per Subject Cost. Xxxxxx Clinical shall pay Principal Investigator the following Per Subject Cost for proper performance of its obligations under this Agreement: 3. Náklady na subjekt Společnost Xxxxxx Clinical bude hradit Hlavnímu zkoušejícímu následující náklady na subjekt za řádné plnění jeho povinností podle této Smlouvy: Breakdown overview of Investigator fee / Podrobné členění poplatků zkoušejícího Study number T817MAEU201 Title A Phase 2 multi-center, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of T-817MA in patients with mild cognitive impairment due to Alzheimer’s Disease or mild Alzheimer’s Disease Czech Republic Currency: CZK
Sample 1

Related to Per Subject Cost

  • Project Cost a. The estimated cost of the Project is $ 97,740.00. This amount is based upon the Schedule of Financial Assistance in Exhibit "B", attached to and incorporated in this Agreement. Exhibit “B” may be modified by mutual execution of an amendment as provided for in paragraph 5.i.

  • Total Project Cost The total cost of the Project is $36,378,683, of which (i) a match is being contributed in the amount of $21,000,000 shall be Matching Funds, and (ii) $15,378,683 shall be provided by the Grant. The total estimated cost of the Project is based upon the Budget. To the extent that the actual cost of the Project exceeds $36,378,683, Grantee shall be solely responsible for such excess. Grantee shall monitor the Budget and submit an amended Budget to Triumph in the event that (a) the total cost of the Project increases or decreases by greater than five percent (5%), (b) total the Budget increases or decreases by greater than five percent (5%), (c) the Budget increases or decreases by greater than five percent (5%) within a particular Budget category, and/or (d) Grantee’s portion of the Matching funds decreases by greater than five percent (5%). If Grantee proposes an increase or decrease by greater than five percent (5%) as described above as compared to the most recently approved Budget, such proposal shall be submitted to Triumph in writing along with a proposed amended Budget, and Triumph shall have the right to approve or disapprove both the proposed Budget category increase or decrease and the proposed amended Budget. If Grantee fails to obtain Triumph's approval, that failure shall be sufficient cause for nonpayment by Triumph as provided in Section 4.2(f). Using the Grant, its own funds, and funds from other sources (including, but not limited to, the Matching Funds), Grantee agrees to bear the entire cost and expense of the Project, including but not limited to, all costs and all expenses in excess of the total estimated cost of the Project, it being expressly understood and agreed that the Grant shall operate only to pay, on and subject to the terms and conditions set forth herein, a portion of the costs and expenses of the Project. Furthermore, Grantee agrees to spend all of the Matching Funds as contemplated in the Budget, and agrees that its failure to do so shall be deemed a material breach of this Agreement.

  • Project Cost Overruns In the event that the Recipient determines that the moneys granted pursuant to Section II hereof, together with the Local Subdivision Contribution, are insufficient to pay in full the costs of the Project, the Recipient may make a request for supplemental assistance to its District Committee. The Recipient must demonstrate that such funding is necessary for the completion of the Project and the cost overrun was the result of circumstances beyond the Recipient's control, that it could not have been avoided with the exercise of due care, and that such circumstances could not have been anticipated at the time of the Recipient's initial application. Should the District Committee approve such request the action shall be recorded in the District Committee's official meeting minutes and provided to the OPWC Director for the execution of an amendment to this Agreement.

  • Construction Cost 3.1. Construction Cost does not include the fees of the ARCHITECT/ENGINEER and consultants, the cost of the land, rights- of-way, or other costs, which is the responsibility of the State as provided in Paragraphs 2.2 through 2.3. or any of the contingencies available for the project unless specifically stated otherwise.

  • Indirect Cost Except as otherwise authorized by this contract, no indirect costs shall be reimbursed.

  • Project Costs Simultaneously with the execution of this Agreement, the Company shall disclose to the Department all of the Project Costs which the Company seeks to include for purposes of determining the limitation of the amount of the Credit pursuant to Section 5-30 of the Act and provide to the Department a Schedule of Project Costs in the form as attached hereto as Exhibit C.

  • Construction Cost Estimate At 50% completion of the contract documents, the design team will present and submit copies of the project plans and manual. The Construction Administrator will prepare and issue the fourth of five construction cost estimates. The estimate shall be derived from actual takeoffs, subcontractor and vendor input, and material and labor cost data. All quantitative systems information shall be provided in detail.

  • Total Project Costs The sum of the Construction Cost, allowances for contingencies, and the total costs of services of Engineer or other design professionals and consultants, together with such other Project-related costs that Owner furnishes for inclusion, including but not limited to cost of land, rights-of-way, compensation for damages to properties, Owner’s costs for legal, accounting, insurance counseling and auditing services, interest and financing charges incurred in connection with the Project, and the cost of other services to be provided by others to Owner pursuant to Exhibit B of this Agreement.

  • Total Cost It is estimated that the total cost to Princeton University for the performance of this Contract shall not exceed the Not-to-Exceed Price set forth in the Contract and the Contractor agrees to use its best efforts to perform the Work specified in the Contract and all obligations under this Contract within such Not-to- Exceed Price. If at any time the Contractor has reason to believe that the hourly rate payments and material costs that will accrue in performing this Contract in the next succeeding thirty (30) days, if added to all other payments and costs previously accrued, will exceed eighty-five percent (85%) of the Not-to-Exceed Price in the Contract, the Contractor shall notify Princeton University giving a revised estimate of the total price for performing this Contract with supporting reasons and documentation. If at any time during performing this Contract, the Contractor has reason to believe that the total price to Princeton University for performing this Contract will be substantially greater or less than stated Not-to-Exceed Price, the Contractor shall so notify Princeton University, giving a revised estimate of the total price for performing this Contract, with supporting reasons and documentation. If at any time during performance of this Contract, Princeton University has reason to believe that the cost required to perform the Work of this Contract will be substantially greater or less than the stated Not-to-Exceed Price, Princeton University will so advise the Contractor, giving the then- revised estimate of the total amount of effort to be required under the Contract.

  • Development Costs With respect to activities prior to the Amendment Effective Date, each Party was to pay [*] of the total Direct Development Costs of a Product incurred in accordance with the Development Budget (as defined in the Original Agreement). Notwithstanding anything in this Article 6 of this Agreement or in any other provision of this Agreement to the contrary, with respect to activities on and after the Amendment Effective Date, subject to Sections 3.1.2, Alimera will be solely responsible for, and shall pay one hundred percent (100%) of, all development costs of a Product, including Direct Development Costs. Notwithstanding anything in this Article 6 of this Agreement or in any other provision of this Agreement to the contrary, (i) all payments owing by CDS hereunder with respect to development activities prior to the Amendment Effective Date are hereby deemed fully paid by CDS (or waived, to the extent such waiver may be required), including any Development Payments, Compounded Development Payments, Determined Disputed Costs and Compounded Disputed Costs (as all defined in the Original Agreement), further including any penalties and interest which might have accrued with respect thereto, and further including all CDS payments deferred pursuant to that February 11, 2008 letter agreement sent by CDS and executed by CDS and Alimera regarding deferral of payments under the Original Agreement as of such date; (ii) all payments owing by Alimera hereunder with respect to development activities prior to the Amendment Effective Date are hereby deemed fully paid by Alimera (or waived, to the extent such waiver may be required), including any Development Payments, Compounded Development Payments, Determined Disputed Costs and Compounded Disputed Costs (as all defined in the Original Agreement), and further including any penalties and interest which might have accrued with respect thereto; and (iii) subject to Sections 3.1.1 and 3.1.2, from and after the Amendment Effective Date, CDS will have no liability whatsoever hereunder for any past, present or future development costs, including Direct Development Costs (which includes those incurred before, on and after the Amendment Effective Date), and instead Alimera shall have sole liability therefor.

Time is Money Join Law Insider Premium to draft better contracts faster.